Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy

Background The postpericardiotomy syndrome (PPS) is a common complication following cardiac surgery. The pathophysiology remains unclear, although evidence exists that surgical trauma and the use of cardiopulmonary bypass provoke an immune response leading to PPS. We hypothesized that an intraoperat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2014-07, Vol.168 (1), p.126-131.e1
Hauptverfasser: Bunge, Jeroen J.H., MD, van Osch, Dirk, MD, Dieleman, Jan M., MD, Jacob, Kirolos A., BSc, Kluin, Jolanda, MD, PhD, van Dijk, Diederik, MD, PhD, Nathoe, Hendrik M., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 131.e1
container_issue 1
container_start_page 126
container_title The American heart journal
container_volume 168
creator Bunge, Jeroen J.H., MD
van Osch, Dirk, MD
Dieleman, Jan M., MD
Jacob, Kirolos A., BSc
Kluin, Jolanda, MD, PhD
van Dijk, Diederik, MD, PhD
Nathoe, Hendrik M., MD, PhD
description Background The postpericardiotomy syndrome (PPS) is a common complication following cardiac surgery. The pathophysiology remains unclear, although evidence exists that surgical trauma and the use of cardiopulmonary bypass provoke an immune response leading to PPS. We hypothesized that an intraoperative dose of dexamethasone decreases the risk of PPS, by reducing this inflammatory response. Methods We performed a subanalysis of the DECS study, which is a multicenter, double-blind, placebo-controlled, randomized trial of 4,494 patients undergoing cardiac surgery with use of cardiopulmonary bypass. The aim of the DECS study was to investigate whether a single intraoperative dose of 1 mg/kg dexamethasone reduced the incidence of a composite of death, myocardial infarction, stroke, renal failure, or respiratory failure, within 30 days of randomization. In this substudy, we retrospectively analyzed the occurrence of PPS in 822 patients who were included in the DECS trial and underwent valvular surgery. Postpericardiotomy syndrome was diagnosed if 2 of 5 listed symptoms were present: unexplained fever, pleuritic chest pain, pericardial or pleural rub, new or worsening pericardial or pleural effusion. All medical charts, x-rays, and echocardiograms were reviewed. Secondary end point was the occurrence of complicated PPS, defined as PPS with need for evacuation of pleural effusion, pericardiocentesis, and tamponade requiring intervention or hospital readmission for PPS. This is a blinded, single-center, post hoc analysis. Results Postpericardiotomy syndrome occurred in 119 patients (14.5%). The incidence of PPS after dexamethasone compared with placebo was 13.5% vs 15.5% (relative risk 0.88, 95% CI 0.63-1.22). For complicated PPS, the incidence was 3.8% versus 3.2% (relative risk 1.17, 95% CI 0.57-2.41, P = .66), respectively. Conclusion In patients undergoing valvular cardiac surgery, high-dose dexamethasone treatment had no protective effect on the occurrence of PPS or complicated PPS.
doi_str_mv 10.1016/j.ahj.2014.03.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1539707797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S000287031400163X</els_id><sourcerecordid>1539707797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-4f1f297555f6eb44166300bfaa7b4c68026c66557754c987402b02404bb0928e3</originalsourceid><addsrcrecordid>eNp9kl2L1TAQhoMo7nH1B3gjBW-8aZ20-WgUhOXsh8KCF6vgXWjTqSe1bWrSLvbfm3JWhXPhVSbwvC8z8w4hLylkFKh422XVoctyoCyDIgMqH5EdBSVTIRl7THYAkKelhOKMPAuhi1-Rl-IpOcuZ4rFSOzJc4q9qwPlQBTdi0jqfzAdMJo_3OM7WjYlrk8mFeUJvTeUb62Y3rElYx8a7Ad8lF8nl1anFfgMrk9wt_jv6SC91mJdmfU6etFUf8MXDe06-Xl992X9Mbz_ffNpf3KaGg5hT1tI2V5Jz3gqsGaNCFAB1W1WyZkaUkAsjBOdScmZUKRnkNeQMWF2Dyksszsmbo-_k3c8Fw6wHGwz2fTWiW4KmvFASpFQyoq9P0M4tfozdbZRQBeWKR4oeKeNdCB5bPXk7VH7VFPSWhe50zEJvWWgodMwial49OC_1gM1fxZ_lR-D9EcC4inuLXgdjcTTYWI9m1o2z_7X_cKI2vR1jRv0PXDH8m0KHXIO-245huwXKIBoW34rfl4KuPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1536931595</pqid></control><display><type>article</type><title>Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Bunge, Jeroen J.H., MD ; van Osch, Dirk, MD ; Dieleman, Jan M., MD ; Jacob, Kirolos A., BSc ; Kluin, Jolanda, MD, PhD ; van Dijk, Diederik, MD, PhD ; Nathoe, Hendrik M., MD, PhD</creator><creatorcontrib>Bunge, Jeroen J.H., MD ; van Osch, Dirk, MD ; Dieleman, Jan M., MD ; Jacob, Kirolos A., BSc ; Kluin, Jolanda, MD, PhD ; van Dijk, Diederik, MD, PhD ; Nathoe, Hendrik M., MD, PhD ; Dexamethasone for Cardiac Surgery (DECS) Study Group</creatorcontrib><description>Background The postpericardiotomy syndrome (PPS) is a common complication following cardiac surgery. The pathophysiology remains unclear, although evidence exists that surgical trauma and the use of cardiopulmonary bypass provoke an immune response leading to PPS. We hypothesized that an intraoperative dose of dexamethasone decreases the risk of PPS, by reducing this inflammatory response. Methods We performed a subanalysis of the DECS study, which is a multicenter, double-blind, placebo-controlled, randomized trial of 4,494 patients undergoing cardiac surgery with use of cardiopulmonary bypass. The aim of the DECS study was to investigate whether a single intraoperative dose of 1 mg/kg dexamethasone reduced the incidence of a composite of death, myocardial infarction, stroke, renal failure, or respiratory failure, within 30 days of randomization. In this substudy, we retrospectively analyzed the occurrence of PPS in 822 patients who were included in the DECS trial and underwent valvular surgery. Postpericardiotomy syndrome was diagnosed if 2 of 5 listed symptoms were present: unexplained fever, pleuritic chest pain, pericardial or pleural rub, new or worsening pericardial or pleural effusion. All medical charts, x-rays, and echocardiograms were reviewed. Secondary end point was the occurrence of complicated PPS, defined as PPS with need for evacuation of pleural effusion, pericardiocentesis, and tamponade requiring intervention or hospital readmission for PPS. This is a blinded, single-center, post hoc analysis. Results Postpericardiotomy syndrome occurred in 119 patients (14.5%). The incidence of PPS after dexamethasone compared with placebo was 13.5% vs 15.5% (relative risk 0.88, 95% CI 0.63-1.22). For complicated PPS, the incidence was 3.8% versus 3.2% (relative risk 1.17, 95% CI 0.57-2.41, P = .66), respectively. Conclusion In patients undergoing valvular cardiac surgery, high-dose dexamethasone treatment had no protective effect on the occurrence of PPS or complicated PPS.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2014.03.017</identifier><identifier>PMID: 24952869</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Aged ; Cardiac Surgical Procedures - adverse effects ; Cardiovascular ; Dexamethasone - administration &amp; dosage ; Dose-Response Relationship, Drug ; Double-Blind Method ; Family medical history ; Female ; Follow-Up Studies ; Glucocorticoids - administration &amp; dosage ; Heart surgery ; Hospitals ; Humans ; Incidence ; Intraoperative Period ; Male ; Middle Aged ; Netherlands - epidemiology ; Pain ; Postpericardiotomy Syndrome - epidemiology ; Postpericardiotomy Syndrome - prevention &amp; control ; Prognosis ; Retrospective Studies ; Studies ; Survival Rate - trends ; Ultrasonic imaging ; Veins &amp; arteries</subject><ispartof>The American heart journal, 2014-07, Vol.168 (1), p.126-131.e1</ispartof><rights>Mosby, Inc.</rights><rights>2014 Mosby, Inc.</rights><rights>Copyright © 2014 Mosby, Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-4f1f297555f6eb44166300bfaa7b4c68026c66557754c987402b02404bb0928e3</citedby><cites>FETCH-LOGICAL-c506t-4f1f297555f6eb44166300bfaa7b4c68026c66557754c987402b02404bb0928e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1536931595?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24952869$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bunge, Jeroen J.H., MD</creatorcontrib><creatorcontrib>van Osch, Dirk, MD</creatorcontrib><creatorcontrib>Dieleman, Jan M., MD</creatorcontrib><creatorcontrib>Jacob, Kirolos A., BSc</creatorcontrib><creatorcontrib>Kluin, Jolanda, MD, PhD</creatorcontrib><creatorcontrib>van Dijk, Diederik, MD, PhD</creatorcontrib><creatorcontrib>Nathoe, Hendrik M., MD, PhD</creatorcontrib><creatorcontrib>Dexamethasone for Cardiac Surgery (DECS) Study Group</creatorcontrib><title>Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background The postpericardiotomy syndrome (PPS) is a common complication following cardiac surgery. The pathophysiology remains unclear, although evidence exists that surgical trauma and the use of cardiopulmonary bypass provoke an immune response leading to PPS. We hypothesized that an intraoperative dose of dexamethasone decreases the risk of PPS, by reducing this inflammatory response. Methods We performed a subanalysis of the DECS study, which is a multicenter, double-blind, placebo-controlled, randomized trial of 4,494 patients undergoing cardiac surgery with use of cardiopulmonary bypass. The aim of the DECS study was to investigate whether a single intraoperative dose of 1 mg/kg dexamethasone reduced the incidence of a composite of death, myocardial infarction, stroke, renal failure, or respiratory failure, within 30 days of randomization. In this substudy, we retrospectively analyzed the occurrence of PPS in 822 patients who were included in the DECS trial and underwent valvular surgery. Postpericardiotomy syndrome was diagnosed if 2 of 5 listed symptoms were present: unexplained fever, pleuritic chest pain, pericardial or pleural rub, new or worsening pericardial or pleural effusion. All medical charts, x-rays, and echocardiograms were reviewed. Secondary end point was the occurrence of complicated PPS, defined as PPS with need for evacuation of pleural effusion, pericardiocentesis, and tamponade requiring intervention or hospital readmission for PPS. This is a blinded, single-center, post hoc analysis. Results Postpericardiotomy syndrome occurred in 119 patients (14.5%). The incidence of PPS after dexamethasone compared with placebo was 13.5% vs 15.5% (relative risk 0.88, 95% CI 0.63-1.22). For complicated PPS, the incidence was 3.8% versus 3.2% (relative risk 1.17, 95% CI 0.57-2.41, P = .66), respectively. Conclusion In patients undergoing valvular cardiac surgery, high-dose dexamethasone treatment had no protective effect on the occurrence of PPS or complicated PPS.</description><subject>Aged</subject><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>Cardiovascular</subject><subject>Dexamethasone - administration &amp; dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Family medical history</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glucocorticoids - administration &amp; dosage</subject><subject>Heart surgery</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Intraoperative Period</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Netherlands - epidemiology</subject><subject>Pain</subject><subject>Postpericardiotomy Syndrome - epidemiology</subject><subject>Postpericardiotomy Syndrome - prevention &amp; control</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Studies</subject><subject>Survival Rate - trends</subject><subject>Ultrasonic imaging</subject><subject>Veins &amp; arteries</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl2L1TAQhoMo7nH1B3gjBW-8aZ20-WgUhOXsh8KCF6vgXWjTqSe1bWrSLvbfm3JWhXPhVSbwvC8z8w4hLylkFKh422XVoctyoCyDIgMqH5EdBSVTIRl7THYAkKelhOKMPAuhi1-Rl-IpOcuZ4rFSOzJc4q9qwPlQBTdi0jqfzAdMJo_3OM7WjYlrk8mFeUJvTeUb62Y3rElYx8a7Ad8lF8nl1anFfgMrk9wt_jv6SC91mJdmfU6etFUf8MXDe06-Xl992X9Mbz_ffNpf3KaGg5hT1tI2V5Jz3gqsGaNCFAB1W1WyZkaUkAsjBOdScmZUKRnkNeQMWF2Dyksszsmbo-_k3c8Fw6wHGwz2fTWiW4KmvFASpFQyoq9P0M4tfozdbZRQBeWKR4oeKeNdCB5bPXk7VH7VFPSWhe50zEJvWWgodMwial49OC_1gM1fxZ_lR-D9EcC4inuLXgdjcTTYWI9m1o2z_7X_cKI2vR1jRv0PXDH8m0KHXIO-245huwXKIBoW34rfl4KuPA</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Bunge, Jeroen J.H., MD</creator><creator>van Osch, Dirk, MD</creator><creator>Dieleman, Jan M., MD</creator><creator>Jacob, Kirolos A., BSc</creator><creator>Kluin, Jolanda, MD, PhD</creator><creator>van Dijk, Diederik, MD, PhD</creator><creator>Nathoe, Hendrik M., MD, PhD</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy</title><author>Bunge, Jeroen J.H., MD ; van Osch, Dirk, MD ; Dieleman, Jan M., MD ; Jacob, Kirolos A., BSc ; Kluin, Jolanda, MD, PhD ; van Dijk, Diederik, MD, PhD ; Nathoe, Hendrik M., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-4f1f297555f6eb44166300bfaa7b4c68026c66557754c987402b02404bb0928e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>Cardiovascular</topic><topic>Dexamethasone - administration &amp; dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Family medical history</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glucocorticoids - administration &amp; dosage</topic><topic>Heart surgery</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Intraoperative Period</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Netherlands - epidemiology</topic><topic>Pain</topic><topic>Postpericardiotomy Syndrome - epidemiology</topic><topic>Postpericardiotomy Syndrome - prevention &amp; control</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Studies</topic><topic>Survival Rate - trends</topic><topic>Ultrasonic imaging</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bunge, Jeroen J.H., MD</creatorcontrib><creatorcontrib>van Osch, Dirk, MD</creatorcontrib><creatorcontrib>Dieleman, Jan M., MD</creatorcontrib><creatorcontrib>Jacob, Kirolos A., BSc</creatorcontrib><creatorcontrib>Kluin, Jolanda, MD, PhD</creatorcontrib><creatorcontrib>van Dijk, Diederik, MD, PhD</creatorcontrib><creatorcontrib>Nathoe, Hendrik M., MD, PhD</creatorcontrib><creatorcontrib>Dexamethasone for Cardiac Surgery (DECS) Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bunge, Jeroen J.H., MD</au><au>van Osch, Dirk, MD</au><au>Dieleman, Jan M., MD</au><au>Jacob, Kirolos A., BSc</au><au>Kluin, Jolanda, MD, PhD</au><au>van Dijk, Diederik, MD, PhD</au><au>Nathoe, Hendrik M., MD, PhD</au><aucorp>Dexamethasone for Cardiac Surgery (DECS) Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>168</volume><issue>1</issue><spage>126</spage><epage>131.e1</epage><pages>126-131.e1</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Background The postpericardiotomy syndrome (PPS) is a common complication following cardiac surgery. The pathophysiology remains unclear, although evidence exists that surgical trauma and the use of cardiopulmonary bypass provoke an immune response leading to PPS. We hypothesized that an intraoperative dose of dexamethasone decreases the risk of PPS, by reducing this inflammatory response. Methods We performed a subanalysis of the DECS study, which is a multicenter, double-blind, placebo-controlled, randomized trial of 4,494 patients undergoing cardiac surgery with use of cardiopulmonary bypass. The aim of the DECS study was to investigate whether a single intraoperative dose of 1 mg/kg dexamethasone reduced the incidence of a composite of death, myocardial infarction, stroke, renal failure, or respiratory failure, within 30 days of randomization. In this substudy, we retrospectively analyzed the occurrence of PPS in 822 patients who were included in the DECS trial and underwent valvular surgery. Postpericardiotomy syndrome was diagnosed if 2 of 5 listed symptoms were present: unexplained fever, pleuritic chest pain, pericardial or pleural rub, new or worsening pericardial or pleural effusion. All medical charts, x-rays, and echocardiograms were reviewed. Secondary end point was the occurrence of complicated PPS, defined as PPS with need for evacuation of pleural effusion, pericardiocentesis, and tamponade requiring intervention or hospital readmission for PPS. This is a blinded, single-center, post hoc analysis. Results Postpericardiotomy syndrome occurred in 119 patients (14.5%). The incidence of PPS after dexamethasone compared with placebo was 13.5% vs 15.5% (relative risk 0.88, 95% CI 0.63-1.22). For complicated PPS, the incidence was 3.8% versus 3.2% (relative risk 1.17, 95% CI 0.57-2.41, P = .66), respectively. Conclusion In patients undergoing valvular cardiac surgery, high-dose dexamethasone treatment had no protective effect on the occurrence of PPS or complicated PPS.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>24952869</pmid><doi>10.1016/j.ahj.2014.03.017</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2014-07, Vol.168 (1), p.126-131.e1
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_1539707797
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Aged
Cardiac Surgical Procedures - adverse effects
Cardiovascular
Dexamethasone - administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Family medical history
Female
Follow-Up Studies
Glucocorticoids - administration & dosage
Heart surgery
Hospitals
Humans
Incidence
Intraoperative Period
Male
Middle Aged
Netherlands - epidemiology
Pain
Postpericardiotomy Syndrome - epidemiology
Postpericardiotomy Syndrome - prevention & control
Prognosis
Retrospective Studies
Studies
Survival Rate - trends
Ultrasonic imaging
Veins & arteries
title Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T05%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dexamethasone%20for%20the%20prevention%20of%20postpericardiotomy%20syndrome:%20A%20DExamethasone%20for%20Cardiac%20Surgery%20substudy&rft.jtitle=The%20American%20heart%20journal&rft.au=Bunge,%20Jeroen%20J.H.,%20MD&rft.aucorp=Dexamethasone%20for%20Cardiac%20Surgery%20(DECS)%20Study%20Group&rft.date=2014-07-01&rft.volume=168&rft.issue=1&rft.spage=126&rft.epage=131.e1&rft.pages=126-131.e1&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2014.03.017&rft_dat=%3Cproquest_cross%3E1539707797%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1536931595&rft_id=info:pmid/24952869&rft_els_id=1_s2_0_S000287031400163X&rfr_iscdi=true